Though she could switch to another insurance plan offered by her employer, Mass General Brigham, it, too, intends to eliminate Zepbound from a list of covered drugs
Kyle Gillett podcast (an expert in hormone optimization)
Incretin Pathways Influencing Reward Circuits Incretin-based medications such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, including tirzepatide, have become important treatments for obesity and diabetes
Do not self-administer unless trained by a doctor
rather, they offer insights into baseline metabolic traits that may influence GLP-1 efficacy or side-effect frequency
Results from a study examining the safety of using liraglutide in patients with moderate to severe renal impairment demonstrated no deleterious effects on serum creatinine (SCr) or increased incidence or severity of adverse events